Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

Eupraxia Pharmaceuticals Inc.’s EPRX share price has surged by 5.46%, which has investors questioning if this is right time ...